
Luxembourg's Science Centre: The Trojan Horse for Tech Elites, Not the People
The new Luxembourg science centre promises public engagement, but it's really a sophisticated talent pipeline for the EU's deep-tech future.

The new Luxembourg science centre promises public engagement, but it's really a sophisticated talent pipeline for the EU's deep-tech future.

The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.

The slow start of the latest Black health study reveals a systemic failure. We analyze the real agenda behind these reports.

Aurobindo's CuraTeQ just snagged Health Canada approval for Dyrupeg, but this isn't just a regulatory win; it's a calculated strike in the escalating global **biosimilar market** battle.

The real shockwave from OpenAI targeting healthcare isn't better diagnoses; it's the massive centralization of patient and provider data.

Behind the curtain of glossy book reviews lies a dangerous trend stifling true science fiction and fantasy.

The recent basketball upset isn't just sports news; it's a stark warning about the widening gap in access to elite **technology** resources and **high school sports**.
The rise of health modeling experts like Wirichada Pan Ngum signals a power shift. But who controls the algorithms shaping our future health policy?

The push for new public health skills ignores the real power shift: from epidemiology to algorithmic control.

The launch of 'Strange Health' signals a dangerous shift: academic insight weaponized for mainstream health narratives. Who truly benefits?

Informal science learning is hailed as the great equalizer, but the hidden agenda benefits funders more than the truly excluded.

The supposed crisis in ice science isn't about melting glaciers; it's about the hidden battle for research funding and academic control.